For instance, a study compared a model including established clinical parameters alone, like the mutational status, grading, Eastern Cooperative Oncology Group performance status, and tumor load or in combination with the mHPP1 ctDNA and/or CEA levels in blood sample before and after therapy [79]. Here, CEACAM5 is linked to neoplasm.